This information is intended only for healthcare professionals resident in the Great Britain

Prescribing Information (PI) for Lorviqua® (lorlatinib) Great Britain (GB) and Northern Ireland (NI)​​​​​​​​​​

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

Great Britain

  • Lorviqua (lorlatinib) -  25mg film coated tablets - PI for GB
  • Lorviqua (lorlatinib) -  100 mg film coated tablets - PI for GB

Northern Ireland

  • Lorviqua (lorlatinib)  -  25mg film coated tablets, 100 mg film coated tablets - PI for NI

Lorviqua (lorlatinib) -  25mg film coated tablets - PI for GB

Lorviqua (lorlatinib) -  100 mg film coated tablets - PI for GB

Lorviqua (lorlatinib)  -  25mg film coated tablets, 100 mg film coated tablets - PI for NI

PP-LQA-GBR-0306 October 2021